Literature DB >> 26840037

Diet, microbiota, and dysbiosis: a 'recipe' for colorectal cancer.

Kishore Vipperla1, Stephen J O'Keefe2.   

Abstract

The food we consume feeds not only us, but also a vast and diverse community of microbiota within our gastrointestinal tract. In a process of symbiotic co-evolution, the gut microbiota became essential for the maintenance of the health and integrity of our colon. The advent of next-generation DNA sequencing technology and metabolic profiling have, in the recent years, revealed the remarkable complexity of microbial diversity and function, and that the microbiota produce a wide variety of bioactive products that are not only active at the mucosal surface, but also absorbed and circulated throughout the body, influencing distant organ health and function. As a result, several microbiota compositional patterns and their associations with both health and disease states have been identified. Importantly, a disturbed microbiota-host relationship, termed dysbiosis, is now recognized to be the root cause for a growing list of diseases, including colorectal cancer (CRC). There is mounting in vitro and in vivo evidence to suggest that diet selects for the microbiota composition and several health promoting and deleterious effects of diet are, in fact, mediated by the microbiota. Recent findings of the feasibility of dietary fiber to boost the colonic microbial synthesis of anti-proliferative and counter carcinogenic metabolites, particularly butyrate, underscores the prerequisite of dietary modification as a key measure to curb the pandemic of CRC in westernized countries. Better understanding of the diet-microbiota interplay and large-scale studies to evaluate the efficacy of dietary modification and gut microbiota modulation in reversing dysbiosis and restoring health could offer novel preventative and/or therapeutic strategies against westernized diseases, which are now considered the chief threat to public health.

Entities:  

Mesh:

Year:  2016        PMID: 26840037      PMCID: PMC6501806          DOI: 10.1039/c5fo01276g

Source DB:  PubMed          Journal:  Food Funct        ISSN: 2042-6496            Impact factor:   5.396


  37 in total

Review 1.  Epigenetic Biomarkers in Colorectal Cancer.

Authors:  Mukesh Verma; Vineet Kumar
Journal:  Mol Diagn Ther       Date:  2017-04       Impact factor: 4.074

2.  Cys34 Adductomics Links Colorectal Cancer with the Gut Microbiota and Redox Biology.

Authors:  Hasmik Grigoryan; Courtney Schiffman; Marc J Gunter; Alessio Naccarati; Silvia Polidoro; Sonia Dagnino; Sandrine Dudoit; Paolo Vineis; Stephen M Rappaport
Journal:  Cancer Res       Date:  2019-10-22       Impact factor: 12.701

Review 3.  Diet, microorganisms and their metabolites, and colon cancer.

Authors:  Stephen J D O'Keefe
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-11-16       Impact factor: 46.802

Review 4.  Microbiota as a mediator of cancer progression and therapy.

Authors:  Jillian L Pope; Sarah Tomkovich; Ye Yang; Christian Jobin
Journal:  Transl Res       Date:  2016-08-03       Impact factor: 7.012

5.  Gut-microbiota-on-a-chip: an enabling field for physiological research.

Authors:  Grissel Trujillo-de Santiago; Matías José Lobo-Zegers; Silvia Lorena Montes-Fonseca; Yu Shrike Zhang; Mario Moisés Alvarez
Journal:  Microphysiol Syst       Date:  2018-10-16

Review 6.  Gut microbiota-derived metabolites in CRC progression and causation.

Authors:  Nishu Dalal; Rekha Jalandra; Nitin Bayal; Amit K Yadav; Minakshi Sharma; Govind K Makharia; Pramod Kumar; Rajeev Singh; Pratima R Solanki; Anil Kumar
Journal:  J Cancer Res Clin Oncol       Date:  2021-07-17       Impact factor: 4.553

Review 7.  Obesity and cancer: inflammation bridges the two.

Authors:  Ryan Kolb; Fayyaz S Sutterwala; Weizhou Zhang
Journal:  Curr Opin Pharmacol       Date:  2016-07-16       Impact factor: 5.547

8.  Establishing high-accuracy biomarkers for colorectal cancer by comparing fecal microbiomes in patients with healthy families.

Authors:  Jian Yang; Dongfang Li; Zhenyu Yang; Wenkui Dai; Xin Feng; Yanhong Liu; Yiqi Jiang; Pingang Li; Yinhu Li; Bo Tang; Qian Zhou; Chuangzhao Qiu; Chao Zhang; Ximing Xu; Su Feng; Daxi Wang; Heping Wang; Wenjian Wang; Yuejie Zheng; Lin Zhang; Wenjie Wang; Ke Zhou; Shuaicheng Li; Peiwu Yu
Journal:  Gut Microbes       Date:  2020-01-23

Review 9.  Nutraceuticals in colorectal cancer: A mechanistic approach.

Authors:  Marco Rossi; S E Y E D Sina Mirbagheri; Ali Keshavarzian; Faraz Bishehsari
Journal:  Eur J Pharmacol       Date:  2018-06-20       Impact factor: 4.432

Review 10.  Gut Microbiota: Influence on Carcinogenesis and Modulation Strategies by Drug Delivery Systems to Improve Cancer Therapy.

Authors:  Runqi Zhu; Tianqun Lang; Wenlu Yan; Xiao Zhu; Xin Huang; Qi Yin; Yaping Li
Journal:  Adv Sci (Weinh)       Date:  2021-03-09       Impact factor: 16.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.